Clustering of unconventional cardiovascular risk factors among Taiwanese hemodialysis patients

Related Experiment Videos

Shih-Yuan Hung1, Hung-Hsiang Liou, Luo-Ping Ger

  • 1Division of Nephrology, Department of Internal Medicine, E-DA Hospital/I-Shou University, Kaohsiung County, Taiwan, ROC.

Insights

Cardiovascular disease (CAVD) is a major risk for hemodialysis (HD) patients. This study identified conventional and novel risk factors, including left ventricular hypertrophy, to better assess CAVD risk in HD populations.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Cardiovascular disease (CAVD) is the leading cause of mortality in chronic hemodialysis (HD) patients.
  • Risk factors for CAVD in this population remain incompletely understood.

Purpose of the Study:

  • To investigate the prevalence of CAVD (coronary heart disease, cerebrovascular disease, peripheral vascular disease) in chronic HD patients.
  • To identify conventional and novel risk factors associated with CAVD in this cohort.

Main Methods:

  • A multicenter cross-sectional survey was conducted involving 995 chronic HD patients from 12 centers in Taiwan.
  • Data on 30 parameters were collected and analyzed using multivariate logistic regression.

Main Results:

  • Prevalence rates for coronary heart disease (CHD), cerebrovascular disease (CVD), and peripheral vascular disease (PVD) were 24.0%, 6.0%, and 5.3%, respectively.
  • Old age and diabetes were significant conventional risk factors for CAVD.
  • Novel correlates included low apolipoprotein A-I and creatinine (CHD), low uric acid (CVD), low hematocrit, and low diastolic blood pressure (PVD).
  • Left ventricular hypertrophy was an independent correlate for all three subtypes of CAVD.

Conclusions:

  • Assessing CAVD risk in HD patients requires considering both conventional and unconventional risk factors.
  • Identifying novel correlates like left ventricular hypertrophy can improve risk stratification for cardiovascular events in hemodialysis patients.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...